Primary Biliary Cholangitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Men and women aged 18 or older
- People who have been diagnosed with liver cancer (hepatocellular carcinoma or cholangiocarcinoma), confirmed by tissue sample or scan
- People who have liver cirrhosis (scarring of the liver), confirmed by scan or tissue sample
- People who have primary sclerosing cholangitis (a condition affecting the bile ducts), confirmed by a specialist scan or tissue sample
- People who have general digestive or stomach symptoms but whose liver appears normal on a scan (to act as a comparison group)
Who may not be able to join:
- People who have had an active infection, or who have been taking medication that suppresses the immune system, within the last eight weeks
- People who have had a different type of cancer within the last five years
- People who have previously had surgery to remove part of their liver
- People who have already started chemotherapy, radiotherapy, or surgery for their liver cancer
- People whose other health conditions would prevent them from providing a breath sample (confirm with trial site)
- Women who are pregnant (this will be checked verbally during the process)
- People who are unable to read, understand, and sign a consent form
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: George Hanna, Imperial College London
Phone: +02075943396
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Diagnostic Accuracy of VOC Analysis for Liver Cancer Detection
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.